THE THROGMORTON TRUST PLC
All information is at 31 August 2009 and unaudited.
Performance at month end is calculated on a cum income basis
One Three One Three
Month Months Year Years
Net asset value# 9.8% 17.4% -1.9% -19.1%
Net asset value* 9.8% 17.4% -1.6% -22.9%
Share price 7.3% 13.1% -3.3% -22.1%
HGSC plus AIM (ex Inv Cos) 11.6% 18.3% -5.5% -14.5%
# NAV performance prior to costs of repaying the debentures early
* NAV performance after costs of repaying the debentures early
Sources: BlackRock and Datastream
At month end
Net asset value Capital only: 131.39p
Net asset value incl Income: 134.16p
Share price: 110.25p
Discount to Capital only NAV: 16.1%
Net yield: 2.2%
Total assets: £110.5m *
Gearing: Nil
Ordinary shares in continuing pool: 82,351,197 **
* Includes current year revenue.
** Excluding treasury shares.
Ten Largest Sector
Weightings % of Total Assets
Software & Computer Services 11.1
Financial Services 9.6
Support Services 7.5
Oil & Gas Producers 7.1
Mining 5.4
Industrial Engineering 5.2
Technology Hardware & Equipment 4.7
Travel & Leisure 4.2
General Retailers 3.9
Pharmaceuticals & Biotechnology 3.6
----
Total 62.3
====
Ten Largest Equity Investments (in alphabetical order)
Company
Aveva Group
BATM Advanced Communications
Brewin Dolphin Holdings
Dechra Pharmaceuticals
Domino Prining Sciences
Fidessa Group
Pace
Rathbone Brothers
Rensburg Sheppards
Victrex
Commenting on the markets, Mike Prentis and Richard Plackett, representing the
Investment Manager noted:
During August the NAV increased by 9.8% on a capital only basis; this was
slightly behind the benchmark which rose by 11.6%. The FTSE 100 rose by 6.5%.
The main contributors to relative underperformance were our holdings in Fidessa
and Enfis. Fidessa shares fell by 4.6% during the month, following a rise of
11.0% in July. Fidessa had announced strong interims during the month with
organic, constant currency sales and operating profits growth of 19% and 22%
respectively. 81% of Fidessa's revenue is now of a recurring nature and it has
a strong balance sheet with £25 million of net cash. Fidessa is one of our
favourite core holdings and continues to have significant long term growth
potential. Our holding in microcap Enfis disappointed as the company announced
sales of its high brightness light emitting diode arrays had grown more slowly
than hoped. This is not an unusual situation for an emerging company with
interesting technology; the potential is good but it is difficult to assess how
much of this will be realised, and how long it will take.
Relative performance was helped, for the second month, by our holding in
Emerald Energy which received a bid from Sinochem. We subsequently sold our
shares in the market, but have added to our holding in Gulfsands, which is
Emerald Energy's 50% partner, and operator, in its key Khurbet East oilfield in
Syria.
In addition to selling the holding in Emerald Energy we also sold our small
holding in Spring Group, which was bid for by Adecco, and our holding in
William Hill, where trading has been disappointing.
We bought a holding in Spirent following a good meeting with the Finance
Director. Spirent is a world leader in the testing of telecoms networks; its
current activity includes carrying out testing of next generation networks for
large US operators. The shares had been somewhat overlooked and were trading at
less than ten times current year earnings despite having a balance sheet which
includes net cash amounting to 20% of the market capitalisation at the time of
purchase. We believe there is scope for earnings upgrades at Spirent.
The CFD portfolio had a strong month with the market rally widening out to
include a number of high quality growth companies in which we have long CFD
positions. We have reduced our net long position slightly in recognition of the
strength of share prices in recent months.
Latest information is available by typing www.blackrock.co.uk/its on the
internet, "BLRKINDEX" on Reuters, "BLRK" on Bloomberg or "8800" on Topic 3 (ICV
terminal).
25 September 2009
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.